Company Filing History:
Years Active: 2011
Title: Kyoung Min Lim: Innovator in Pharmaceutical Chemistry
Introduction
Kyoung Min Lim is a notable inventor based in Suwon-si, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that have therapeutic effects on inflammatory and immunological disorders.
Latest Patents
Kyoung Min Lim holds a patent for "2-cyclopenten-1-one oxime derivatives inhibiting production of TNF-α." This patent describes the use of 2-cyclopenten-1-one oxime derivatives, represented by Formula (I), or their pharmaceutically acceptable salts, which inhibit the production of TNF-α or PDE4. These compounds demonstrate potential therapeutic effects in treating disorders mediated through TNF-α or PDE4.
Career Highlights
Kyoung Min Lim is currently employed at Amorepacific Corporation, a leading company in the beauty and cosmetics industry. His work focuses on innovative solutions that enhance health and wellness through advanced pharmaceutical applications.
Collaborations
Some of his notable coworkers include Yeonjoon Kim and Sun-Young Kim, who contribute to the collaborative efforts in research and development within the company.
Conclusion
Kyoung Min Lim's innovative work in pharmaceutical chemistry exemplifies the impact of research on health and wellness. His contributions continue to pave the way for advancements in therapeutic solutions.